Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.
Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model.
نویسندگان: سعیده راضی صوفیانی , توحید کاظمی , فرزانه لطفی پور بناب , داریوش شانه بندی , سمیه حلاج نژادی , بهزاد برادران
کلمات کلیدی: Gene therapy; IL-12; in vivo;tumor
نشریه: 0 , 44 , 8 , 2016
| نویسنده ثبت کننده مقاله |
بهزاد برادران |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات ایمونولوژی |
| کد مقاله |
59519 |
| عنوان فارسی مقاله |
Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model. |
| عنوان لاتین مقاله |
Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model. |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
https://www.ncbi.nlm.nih.gov/pubmed/26759095 |
| Context Immunotherapy is among the most promising modalities for treatment of cancer.
Recently, interleukin 12 (IL-12) has been used as an immunotherapeutic agent in cancer gene
therapy. IL-12 can activate dendritic cells (DCs) and boost anti-tumor immune responses. Objective
In the current study, we have investigated if IL-12 gene therapy can lead to the regression of tumor
mass in a mouse model of fibrosarcoma. Material and methods To investigate the therapeutic
efficacy of IL-12, WEHI-164 tumor cells were transfected with murine-IL12 plasmids using
Lipofectamine. Enzyme linked immunosorbent assay (ELISA) was used to confirm IL-12 expression
in transfected cells. The fibrosarcoma mouse model was established by subcutaneous injection of
transfected cells to Balb/C mice. Mice were sacrificed and the tumors were extracted. Tumor sizes
were measured by caliper. The expression of IL-12 and IFN-g was studied with real-time PCR and
western blotting. The expression of Ki-67(a tumor proliferation marker) in tumor mass was studied
by immunohistochemistry staining. Results and discussion The group treated with IL-12 showed a
significant decrease in tumor mass volume (P: 0.000). The results of real-time PCR and western
blotting showed that IL-12 and IFN-g expression increased in the group treated with IL-12 (relative
expression of IL-12: 1.9 and relative expression of IFN-g: 1.766). Immunohistochemistry staining
showed that Ki-67 expression was reduced in the group treated with IL-12. Conclusion IL-12 gene
therapy successfully led to regress of tumor mass in the fibrosarcoma mouse model. This may serve
as a candidate therapeutic approach for treatment of cancer. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 141-Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma.pdf | 1395/09/20 | 879908 | دانلود |